Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models

The rapid scale-up of research on coronavirus disease 2019 (COVID-19) has spawned a large number of potential vaccines and immunotherapies, accompanied by a commensurately large number of in vitro assays and in vivo models to measure their effectiveness. These assays broadly have the same end-goal —...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoury, David S., Wheatley, Adam K., Ramuta, Mitchell D., Reynaldi, Arnold, Cromer, Deborah, Subbarao, Kanta, O’Connor, David H., Kent, Stephen J., Davenport, Miles P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605490/
https://www.ncbi.nlm.nih.gov/pubmed/33139888
http://dx.doi.org/10.1038/s41577-020-00471-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605490/
https://www.ncbi.nlm.nih.gov/pubmed/33139888
http://dx.doi.org/10.1038/s41577-020-00471-1

Ejemplares similares